It is well known that chronic inflammation can increase a person’s cancer risk, but the underlying mechanisms remain unknown. Now, a new study reveals, in a mouse model of colitis, gut tissues may ...

The newest production line at the Milford site represents the largest expansion in Rentschler Biopharma’s more than 150-year history.

Merck & Co. has agreed to acquire Terns Pharmaceuticals for approximately $6.7 billion, in a deal designed to bolster the buyer’s cancer pipeline with that of Terns—led by an oral tyrosine kinase ...

There are three technical enablers “that repeatedly separate successful [AI] deployments from stalled pilots: trustworthy data pipelines, fit-for-purpose model selection, and lifestyle governance,” ...

X-Cell generalizes to new biological contexts and breaks barriers as the first scaling law demonstrator in the virtual cell domain.

AI is already helping the biopharmaceutical industry to optimize its manufacturing activities, according to IFPMA.

Scout-triggered mass spectrometry improves host-cell protein monitoring across diverse bioprocessing matrices in one ...

Whether Judge Murphy’s ruling holds through appeal will determine how much institutional credibility can be recovered.

Skin wound healing shows a unique cellular function mechanism involving the interaction of several cells, growth factors, and ...

A new approach engineers immune cells to recognize byproducts of cancer cells to trigger migration toward the tumor.

Scientists suggest findings highlight potential targets and could lead to the development of therapies that specifically block the tumor’s ability to spread.

Artis was founded to provide platforms and capabilities that drug developers require to bring next-generation medicines to patients.